Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-03

Clinical Trial Update: a Prospective Cohort Study for Propranolol Treatment in Retinopathy of Prematurity [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 prospective cohort trial evaluating propranolol for retinopathy of prematurity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: Guangdong Women and Children Hospital | Conditions: Retinopathy of Prematurity | Phase 2 | Status: UNKNOWN